PRECIGEN THERAPEUTICS

Welcome to the Brand page for “PRECIGEN THERAPEUTICS”, which is offered here for Chemical preparations for medical and veterinary purposes, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; biochemical preparations for medical and veterinary purposes, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; chemical reagents for medical and veterinary purposes, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders;chemicals, biochemicals and reagents for use in industry and science; chemicals, biochemicals and reagents, proteins for regulating, modifying or restricting gene expression; kits consisting primarily of proteins for regulating, modifying or restricting gene expression;technology transfer services, licensing of intellectual property;medical services; medical services, genetic engineering, biopharmaceuticals and gene therapy services; healthcare services, treatment of patients with genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; medical services, providing medical therapy treatments which are under development or have completed development for patients in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular diseases;therapeutics;scientific research and development services in the field of medicine, pharmacology, immunology, biochemistry, cell biology, genetics, microbiology and virology; scientific research in the field of healthcare; therapeutic research of treatments in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular disease which are under development or have completed development; development of products being genetic therapies, biopharmaceuticals, and effectors to regulate, modulate, and characterize disease states; development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; research and development services for others in the field of biotechnology, genetically engineering dna, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; research and development services for others in the fields of genetics and biotechnology, genetically engineering dna, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use;.

Its status is currently believed to be active. Its class is unavailable. “PRECIGEN THERAPEUTICS” is believed to be currently owned by “PRECIGEN, INC.”